TissGeneSummary for TRIB3 |
Gene summary |
Basic gene information | Gene symbol | TRIB3 |
Gene name | tribbles pseudokinase 3 | |
Synonyms | C20orf97|NIPK|SINK|SKIP3|TRB3 | |
Cytomap | UCSC genome browser: 20p13-p12.2 | |
Type of gene | protein-coding | |
RefGenes | NM_001301188.1, NM_001301190.1,NM_001301193.1,NM_001301196.1,NM_001301201.1, NM_021158.4, | |
Description | TRB-3neuronal cell death inducible putative kinaseneuronal cell death-inducible putative kinasep65-interacting inhibitor of NF-kappa-Bp65-interacting inhibitor of NF-kappaBtribbles homolog 3 | |
Modification date | 20141207 | |
dbXrefs | MIM : 607898 | |
HGNC : HGNC | ||
Ensembl : ENSG00000101255 | ||
HPRD : 09836 | ||
Vega : OTTHUMG00000031627 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_TRIB3 | |
BioGPS: 57761 | ||
Pathway | NCI Pathway Interaction Database: TRIB3 | |
KEGG: TRIB3 | ||
REACTOME: TRIB3 | ||
Pathway Commons: TRIB3 | ||
Context | iHOP: TRIB3 | |
ligand binding site mutation search in PubMed: TRIB3 | ||
UCL Cancer Institute: TRIB3 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | CervixLiver | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | CESCLIHC | |
Reference showing the relevant tissue of TRIB3 | ||
Description by TissGene annotations | Cancer gene Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0006469 | negative regulation of protein kinase activity | 12791994 | GO:0034976 | response to endoplasmic reticulum stress | 15775988 | GO:0043405 | regulation of MAP kinase activity | 15299019 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 15775988 | GO:0006469 | negative regulation of protein kinase activity | 12791994 | GO:0034976 | response to endoplasmic reticulum stress | 15775988 | GO:0043405 | regulation of MAP kinase activity | 15299019 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 15775988 |
Top |
TissGeneExp for TRIB3 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
BRCA | 1.77190663 | 0.222877683 | 1.549028947 | 6.65E-31 | 9.37E-30 |
KICH | 1.586971121 | -0.635340879 | 2.222312 | 2.67E-06 | 9.34E-06 |
STAD | 0.999090621 | -0.941712504 | 1.940803125 | 2.39E-07 | 5.43E-06 |
HNSC | 1.436379866 | 0.230810098 | 1.205569767 | 4.11E-07 | 3.48E-06 |
KIRC | 1.858348955 | -0.982771879 | 2.841120833 | 1.44E-28 | 2.43E-27 |
COAD | 2.596256967 | -1.039950725 | 3.636207692 | 1.09E-25 | 2.39E-22 |
LUSC | 1.673283513 | 0.409038415 | 1.264245098 | 7.18E-08 | 2.05E-07 |
ESCA | 1.577648576 | -0.591442333 | 2.169090909 | 0.00159 | 0.019866067 |
KIRP | 0.290018746 | -1.072778129 | 1.362796875 | 0.00145 | 0.00381561 |
BLCA | 1.244197858 | -0.461854773 | 1.706052632 | 0.000108 | 0.001154769 |
Top |
TissGene-miRNA for TRIB3 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for TRIB3 |
TissGeneSNV for TRIB3 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.V226M | STAD | 1 |
p.R149* | PAAD | 1 |
p.A112T | STAD | 1 |
p.E152K | CESC | 1 |
p.L170P | STAD | 1 |
p.R289C | SKCM | 1 |
p.L304V | SKCM | 1 |
p.R36* | UCEC | 1 |
p.K219E | THYM | 1 |
p.R316* | ESCA | 1 |
p.A169T | UCEC | 1 |
p.P300L | ESCA | 1 |
p.D218G | COAD | 1 |
p.V208M | BLCA | 1 |
p.L52S | LUSC | 1 |
p.P155S | SKCM | 1 |
p.R56H | UCEC | 1 |
p.A59V | STAD | 1 |
p.L329V | BLCA | 1 |
p.R139Q | COAD | 1 |
p.S206F | BLCA | 1 |
p.G368V | LUSC | 1 |
p.E302K | BLCA | 1 |
p.A55V | UCEC | 1 |
p.V62L | LUAD | 1 |
p.R274C | STAD | 1 |
p.G211R | LUAD | 1 |
p.R316X | ESCA | 1 |
p.R149X | PAAD | 1 |
p.R29H | STAD | 1 |
p.A112T | ESCA | 1 |
p.R275H | THCA | 1 |
p.T168I | SKCM | 1 |
p.V276L | LUSC | 1 |
p.R29H | UCEC | 1 |
p.R36Q | UCEC | 1 |
p.V226M | UCEC | 1 |
p.R67S | SKCM | 1 |
p.R81Q | READ | 1 |
p.K299N | CESC | 1 |
p.R191H | UCEC | 1 |
p.R2* | UCEC | 1 |
p.R293S | SKCM | 1 |
p.P52S | SKCM | 1 |
p.R108W | LUSC | 1 |
p.Q32H | BRCA | 1 |
p.A277T | UCEC | 1 |
p.R326Q | LUAD | 1 |
Top |
TissGeneCNV for TRIB3 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for TRIB3 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BP240144 | TRIB3-NADK2 | chr20:368874 | chr5:36227578 | |
Chimerdb3.0 | ChiTaRs | NA | U02019 | TRIB3-WASF2 | chr20:377410 | chr1:27783598 | |
TCGAfusionPortal | PRADA | LGG | TCGA-DU-8163-01A | BMP2-TRIB3 | 5UTR-CDS | Chr20:6749522 | Chr20:368655 |
TCGAfusionPortal | PRADA | LUAD | TCGA-75-6211-01A | TRIB3-DEFB125 | Out-of-frame | Chr20:368945 | Chr20:76646 |
Top |
TissGeneNet for TRIB3 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for TRIB3 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for TRIB3 |
TissGeneDrug for TRIB3 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for TRIB3 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 8 | BeFree,GAD |
umls:C0006142 | Malignant neoplasm of breast | 5 | BeFree |
umls:C0678222 | Breast Carcinoma | 5 | BeFree |
umls:C0007222 | Cardiovascular Diseases | 3 | BeFree |
umls:C0020456 | Hyperglycemia | 3 | BeFree |
umls:C1458155 | Mammary Neoplasms | 3 | BeFree |
umls:C0003850 | Arteriosclerosis | 2 | BeFree |
umls:C0004153 | Atherosclerosis | 2 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 2 | BeFree |
umls:C0011847 | Diabetes | 2 | BeFree |
umls:C0011849 | Diabetes Mellitus | 2 | BeFree |
umls:C0021655 | Insulin Resistance | 2 | CTD_human,GAD |
umls:C0027627 | Neoplasm Metastasis | 2 | BeFree |
umls:C0271650 | Impaired glucose tolerance | 2 | BeFree |
umls:C0524620 | Metabolic Syndrome X | 2 | BeFree,CTD_human,GAD |
umls:C1527249 | Colorectal Cancer | 2 | BeFree |
umls:C0002395 | Alzheimer's Disease | 1 | GAD |
umls:C0003130 | Anoxia | 1 | LHGDN |
umls:C0010054 | Coronary Arteriosclerosis | 1 | BeFree |
umls:C0010068 | Coronary heart disease | 1 | BeFree |
umls:C0023418 | leukemia | 1 | BeFree |
umls:C0023467 | Leukemia, Myelocytic, Acute | 1 | BeFree |
umls:C0027051 | Myocardial Infarction | 1 | BeFree |
umls:C0028754 | Obesity | 1 | BeFree |
umls:C0029408 | Degenerative polyarthritis | 1 | BeFree |
umls:C0030297 | Pancreatic Neoplasm | 1 | BeFree |
umls:C0151744 | Myocardial Ischemia | 1 | GAD |
umls:C0243050 | Cardiovascular Abnormalities | 1 | BeFree |
umls:C0311277 | Obesity, Abdominal | 1 | BeFree |
umls:C0349566 | Squamous cell carcinoma of tongue | 1 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 1 | BeFree |
umls:C0521158 | Recurrent tumor | 1 | BeFree |
umls:C0577631 | Carotid Atherosclerosis | 1 | BeFree |
umls:C0596263 | Carcinogenesis | 1 | BeFree |
umls:C0598608 | Hyperhomocysteinemia | 1 | BeFree |
umls:C0600139 | Prostate carcinoma | 1 | BeFree |
umls:C0850666 | Helicobacter pylori infection | 1 | BeFree |
umls:C1318485 | Liver regeneration disorder | 1 | BeFree |
umls:C1956346 | Coronary Artery Disease | 1 | BeFree |
umls:C3495426 | Homocysteinemia | 1 | BeFree |